Patents by Inventor RABEA HINKEL

RABEA HINKEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230173023
    Abstract: A method of treating an ischemic heart disease in a subject in need thereof is provided. The method comprises administering to the subject a therapeutically effective amount of Agrin in an anterograde intracoronary manner, thereby treating the ischemic heart disease in the subject.
    Type: Application
    Filed: February 7, 2023
    Publication date: June 8, 2023
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Eldad Tzahor, Kfir Baruch Umansky, Rabea Hinkel, Christian Kupatt
  • Publication number: 20200306343
    Abstract: A method of treating an ischemic heart disease in a subject in need thereof is provided. The method comprises administering to the subject a therapeutically effective amount of Agrin in an anterograde intracoronary manner, thereby treating the ischemic heart disease in the subject.
    Type: Application
    Filed: June 3, 2020
    Publication date: October 1, 2020
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Eldad TZAHOR, Kfir Baruch UMANSKY, Rabea HINKEL, Christian KUPATT
  • Publication number: 20170096682
    Abstract: The invention relates to the provision of a gene therapy for coronary heart disease and peripheral ischemia in mammals. One embodiment is an adeno-associated viral vector (AAV vector) comprising a first gene encoding a myocardin-related transcription factor A (MRTF-A). The invention further also relates to a pharmaceutical composition comprising an AAV vector of the invention and a pharmaceutically acceptable carrier. Methods for preparing the vector of the invention are also disclosed.
    Type: Application
    Filed: April 13, 2015
    Publication date: April 6, 2017
    Inventors: CHRISTIAN KUPATT, RABEA HINKEL